Press release
SWOT Analysis of Adenosine Receptor A3 Market Excessive Growth Opportunities Estimated to be Experienced by 2025 | Leading Players - Can-Fite BioPharma, Huons Global
Adenosine Receptor A3 Market
The report covers a forecast and an analysis of the Adenosine Receptor A3 Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Adenosine Receptor A3 Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Adenosine Receptor A3 Market on a global level.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/269793 .
In terms of the geographic analysis, The Adenosine Receptor A3 Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Adenosine Receptor A3 Market ecosystem results in the increasing adoption of these systems in North America.
This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Adenosine Receptor A3 Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.
Global Key Players:
1 Can-Fite BioPharma Ltd
2 Huons Global Co Ltd
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Adenosine Receptor A3 Market Report 2020” @ https://www.businessindustryreports.com/buy-now/269793/single .
Product Type Segmentation
1 HU-010
2 LJ-1888
3 CF-602
4 FM-101
5 FM-1101
Industry Segmentation
1 Toxicology
2 Central Nervous System
3 Dermatology
4 Solid Tumor
5 Atopic Dermatitis
On the basis of Regional analysis, North America and Europe holds major share in global Adenosine Receptor A3 market. Moreover, Asia-Pacific is expected to record higher growth rate in Adenosine Receptor A3 Market during the forecast year.
Latest Industry News:
Can-Fite BioPharma (June 04, 2020) - Can-Fite Concludes Successful Meeting with European Medicines Agency (EMA) Regarding Phase III Trial and Registration Plan for Namodenoson in the Treatment of Liver Cancer - Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced it has successfully concluded a meeting with the Scientific Advice Working Party (SAWP) of the European Medicines Agency (EMA) regarding Phase III development of its drug candidate Namodenoson in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Namodenoson is Can-Fite’s adenosine A3 receptor (A3AR) agonist which has recently been shown to prolong median overall survival (OS) in a selected patient population with HCC in a Phase II clinical trial. Can-Fite sought scientific advice from the EMA to complement previous input from the U.S. Food and Drug Administration (FDA) in its recent End-of-Phase II meeting regarding plans for a Phase III registration trial of Namodenoson in patients with HCC and Child Pugh Class B7 (CPB7) cirrhosis. Having completed its meeting with the SAWP, Can-Fite now has sufficient regulatory input to conduct a registration trial in accordance with the requirements of both the U.S. and the European Union.
The planned trial, a randomized, double blind, placebo controlled trial, will enroll approximately 450 patients with HCC and underlying CPB7 cirrhosis at multiple centers worldwide. Patients will be randomized to oral treatment with either Namodenoson 25 mg or matching placebo given twice daily. The primary efficacy endpoint of the trial is overall survival (OS), based on the favorable OS response seen in the Phase II trial in patients with HCC and CPB7 cirrhosis. Other oncology trial efficacy outcomes, such as tumor radiographic response rates and median progression-free survival, as well as standard safety parameters, will be assessed.
“We appreciate the EMA’s advice which, combined with the input we received last October from the U.S. FDA along with recommendations from our academic key opinion leaders, gives us excellent guidance for conducting a successful Phase III clinical and registration program,” stated Can-Fite CEO Dr. Pnina Fishman.
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/269793 .
Major Points in Table of Contents:
Global Adenosine Receptor A3 Market Report 2020
1 Adenosine Receptor A3 Product Definition
2 Global Adenosine Receptor A3 Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Adenosine Receptor A3 Shipments
2.2 Global Manufacturer Adenosine Receptor A3 Business Revenue
2.3 Global Adenosine Receptor A3 Market Overview
2.4 COVID-19 Impact on Adenosine Receptor A3 Industry
3 Manufacturer Adenosine Receptor A3 Business Introduction
3.1 Can-Fite BioPharma Ltd Adenosine Receptor A3 Business Introduction
3.2 Huons Global Co Ltd Adenosine Receptor A3 Business Introduction
About us
BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SWOT Analysis of Adenosine Receptor A3 Market Excessive Growth Opportunities Estimated to be Experienced by 2025 | Leading Players - Can-Fite BioPharma, Huons Global here
News-ID: 2083295 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Adenosine
Rising Disease Incidence Drives Growth In Adenosine Triphosphate (ATP) Assay Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Adenosine Triphosphate (ATP) Assays Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, there has been a swift expansion in the size of the adenosine triphosphate (ATP) assays market. The market, which was worth $1.99 billion in 2024, is predicted to…
Rising Disease Incidence Drives Growth In Adenosine Triphosphate (ATP) Assay Mar …
The Adenosine Triphosphate (ATP) Assays Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Adenosine Triphosphate (ATP) Assays Market Size During the Forecast Period?
The Adenosine Triphosphate (ATP) Assays Market Report by The Business Research Company delivers a detailed market assessment, covering size…
Extensive Adenosine Production Cost: A Comprehensive Overview
Adenosine, a naturally occurring nucleoside, plays a crucial role in various biological processes such as energy transfer, cellular signaling, and regulation of blood flow. Due to its wide range of applications in the pharmaceutical, biotechnology, and medical industries, the production of adenosine has become an integral part of modern scientific development. Understanding the adenosine production cost is essential for businesses involved in this field, as it helps optimize production methods,…
Adenosine Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Adenosine market analysis, which studies the Adenosine's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Adenosine Market 2020-2025” Research Report categorizes the global Adenosine market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth rate, opportunities and trends,…
Global Adenosine Deaminase Deficiency Therapeutic Market Research Report 2018-20 …
The global market status for Adenosine Deaminase Deficiency Therapeutic is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Adenosine Deaminase Deficiency Therapeutic Market” Insights, Forecast to 2025, which tends to deliver in-depth knowledge associated to the Adenosine Deaminase Deficiency Therapeutic market for the present and forecasted period until 2025. Furthermore, the report examines the target…
Latest Trends in Adenosine Market 2018: QY Research
Global Adenosine Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2018 to 2025.
The report of global Adenosine market includes the competitive landscape section which provides the full and in-depth analysis of the current…
